Myocarditis News and Research

RSS

In medicine (cardiology), myocarditis is inflammation of heart muscle (myocardium). It resembles a heart attack but coronary arteries are not blocked.

Vaccination rate remains unchanged but misinformation about flu and Covid-19 stays

Although the public had been alerted that this winter could be a potentially bad flu season, barely half of Americans said in January that they had received a flu shot, a vaccination level unchanged in a representative national panel from the comparable period last year, according to a new Annenberg Science Knowledge (ASK) survey by the Annenberg Public Policy Center of the University of Pennsylvania.

17 Feb 2023

Increasing numbers of cancer survivors at high risk for cardiovascular disease

American Cancer Society (ACS) research estimates there are more than 18 million adult survivors of cancer in the United States, and that number is expected to climb to more than 22 million by 2030.

15 Feb 2023

The safety profile and the actual known adverse effects of COVID-19 vaccines in at-risk and healthy individuals

Researchers discussed the safety of COVID-19 vaccines in healthy people and patients with autoimmunity or cardiac issues.

7 Feb 2023

Effect of risk communication format on COVID-19 vaccine-related risks

In a recent study published in Healthcare, researchers investigated the association between risk-communication format and perceived coronavirus disease 2019 (COVID-19) vaccine-related risks.

2 Feb 2023

A new report examines the safety of bivalent COVID boosters among 1.7 million over-50s

In a recent study posted to medRxiv*, researchers in Denmark examined the risk of adverse events after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron-based bivalent booster vaccination.

24 Jan 2023

New study evaluates the safety profile of the BNT162b2 vaccine in New Zealand

Researchers determined the association between adverse events of special interest (AESIs) following BNT162b2 vaccination, a coronavirus disease 2019 (COVID-19) vaccine based on the messenger ribonucleic acid (mRNA) technology.

24 Jan 2023

Analysis of adverse events in older US adults after COVID-19 mRNA vaccination

Researchers evaluated adverse events in older adults after mRNA vaccination for COVID-19.

24 Jan 2023

What was the prevalence of adverse events following first and second dose COVID-19 vaccinations in England?

A recent Eurosurveillance study focused on estimating the incidence of a prespecified list of adverse events following the first and second doses of the COVID-19 vaccination.

23 Jan 2023

Heart symptoms persist in 10% of patients with long-COVID

In a recent study posted to the medRxiv* preprint server, researchers described the long-term cardiac symptoms associated with coronavirus disease 2019 (COVID-19).

22 Jan 2023

Free spike proteins in the blood appear to play a role in myocarditis post-COVID mRNA vaccine

A recent study published in the journal Circulation examines the immunological picture in this scenario, looking for clues to the etiology of this rare and potentially serious complication.

5 Jan 2023

Are patients with a history of MIS-C at increased risk of adverse reactions from COVID-19 vaccination?

Researchers investigated the reactogenicity of the COVID-19 vaccine in pediatric patients with MIS-C.

5 Jan 2023

Analyzing electronic medical records to identify COVID-19 sequelae

In a recent study published in the journal Emerging Infectious Diseases, researchers analyzed and compared pre‒ and post‒COVID-19 diagnostic codes to identify symptoms that had higher encounter incidence in the post‒COVID-19 period as sequelae. COVID-19 sequelae and future emerging diseases can be generated and monitored using this method.

3 Jan 2023

Cardiac MRI of individuals with acute or post-acute COVID-19

In a recent study published in the Journal of Clinical Ultrasound, researchers in Italy reported cardiac magnetic resonance (CMR) findings in individuals with myocarditis-like syndrome during the acute phase of SARS-CoV-2 infection (AMCovS) and post-acute phase (cPACS).

3 Jan 2023

COVID-19 vaccine safe for children who have had MIS-C

A study of children and adolescents who received a COVID-19 vaccination following multisystem inflammatory syndrome (MIS-C) found that there were no reports of serious complications including myocarditis or MIS-C reoccurrence.

3 Jan 2023

Underlying genetic cause for MIS-C complications after COVID-19 identified

A recent Science journal study determined the underlying cause of MIS-C related to SARS-CoV-2 in some children. It hypothesized that monogenic inborn errors of immunity (IEI) is the primary reason for this condition. Identifying these inborn errors is expected to help elucidate the disease's cellular, molecular, and immunological basis.

2 Jan 2023

Study provides safety assurance to the global population regarding COVID-19 booster vaccines

Study finds a lower mortality rate among individuals with myocarditis after mRNA vaccination than those with viral infection–related myocarditis

Researchers compared the prognosis of myocarditis developing after BNT162b2 mRNA COVID-19 vaccination with viral myocarditis over six months.

20 Dec 2022

Myocarditis News and Research

Further Reading

Vaccination rate remains unchanged but misinformation about flu and Covid-19 stays

Increasing numbers of cancer survivors at high risk for cardiovascular disease

The safety profile and the actual known adverse effects of COVID-19 vaccines in at-risk and healthy individuals

Effect of risk communication format on COVID-19 vaccine-related risks

A new report examines the safety of bivalent COVID boosters among 1.7 million over-50s

New study evaluates the safety profile of the BNT162b2 vaccine in New Zealand

Analysis of adverse events in older US adults after COVID-19 mRNA vaccination

What was the prevalence of adverse events following first and second dose COVID-19 vaccinations in England?

Heart symptoms persist in 10% of patients with long-COVID

Free spike proteins in the blood appear to play a role in myocarditis post-COVID mRNA vaccine

Are patients with a history of MIS-C at increased risk of adverse reactions from COVID-19 vaccination?

Analyzing electronic medical records to identify COVID-19 sequelae

Cardiac MRI of individuals with acute or post-acute COVID-19

COVID-19 vaccine safe for children who have had MIS-C

Underlying genetic cause for MIS-C complications after COVID-19 identified

Study provides safety assurance to the global population regarding COVID-19 booster vaccines

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

Researchers devise new biomarker-based strategy to screen for myocarditis caused by cancer treatment

Study finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccination

Study finds a lower mortality rate among individuals with myocarditis after mRNA vaccination than those with viral infection–related myocarditis

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News